Detalhe da pesquisa
1.
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
N Engl J Med
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785209
2.
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
Diabetologia
; 67(1): 3-18, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801140
3.
Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial.
Circulation
; 147(13): 1004-1013, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802715
4.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
N Engl J Med
; 385(10): 896-907, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215025
5.
Supporting the 'lived expertise' of older adults with type 1 diabetes: An applied focus group analysis to characterize barriers, facilitators, and strategies for self-management in a growing and understudied population.
Diabet Med
; 41(1): e15156, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37278610
6.
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
Diabetes Obes Metab
; 26(5): 1714-1722, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317618
7.
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial.
Diabetes Obes Metab
; 26(4): 1216-1223, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116691
8.
A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular Vesicles.
Mol Cell Proteomics
; 21(12): 100438, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332889
9.
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial.
Circulation
; 145(8): 565-574, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775781
10.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
N Engl J Med
; 383(15): 1425-1435, 2020 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966714
11.
Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity.
J Nutr
; 153(4): 1178-1188, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841667
12.
More hypoglycemia not associated with increasing estimated adiposity in youth with type 1 diabetes.
Pediatr Res
; 93(3): 708-714, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729217
13.
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
Nephrol Dial Transplant
; 38(9): 2041-2051, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651820
14.
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.
Diabetes Obes Metab
; 25(5): 1385-1397, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700417
15.
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin.
Diabetes Obes Metab
; 25(3): 758-766, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394384
16.
Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results.
Diabetes Obes Metab
; 25(3): 688-699, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36314293
17.
Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes.
Nutr Metab Cardiovasc Dis
; 33(2): 388-398, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36586772
18.
A Novel Endocrine Role for the BAT-Released Lipokine 12,13-diHOME to Mediate Cardiac Function.
Circulation
; 143(2): 145-159, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106031
19.
Vitamin D Supplementation and Prevention of Type 2 Diabetes.
N Engl J Med
; 381(6): 520-530, 2019 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173679
20.
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.
Rev Endocr Metab Disord
; 23(5): 979-994, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838946